FDA grants Breakthrough Device Designation for Medtronic’s Valiant TAAA System
The Valiant TAAA has been designed to offer an advanced endovascular solution to enhance patient applicability for difficult…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Oct 19
The Valiant TAAA has been designed to offer an advanced endovascular solution to enhance patient applicability for difficult…
09 Oct 19
Introduction of Orbital Atherectomyin the Middle East expands treatment options for patients with peripheral artery disease
09 Oct 19
BioVentrix has designed REVIVE-HF study to enrol 180 patients to evaluate the treatment of ischemic cardiomyopathy induced heart…
07 Oct 19
EP Map offers 3D mapping and navigation system with integrated signal recording and pacing system, radiofrequency ablation generator…
03 Oct 19
The results once again confirm that AdjuCor’s extravascular technology provides circulatory support without any complex blood contact and…
03 Oct 19
Endotronix intends to use the funding proceeds for PROACTIVE-HF IDE clinical trial and commercialisation of the Cordella Heart…
01 Oct 19
The AltaValve is a Transcatheter Mitral Valve Replacement (TMVR) device designed to broaden the treatable patient population
30 Sep 19
Cost effectiveness data are often used by many payers and health authorities around the world when making coverage…
30 Sep 19
The trial will assess the safety and performance of the Intrepid TMVR system with the transfemoral approach in…
27 Sep 19
The Cor TRICUSPID is a next generation, first of its kind, biologic, seamless, and stent-less cardiac valve composed…